Display Options:
Total: 1404
Antibody
Approved
Unknown
Unknown
Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Follicular; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Neoplasms
B-lymphocyte antigen CD19 binding agent
Antibody
Approved
Unknown
Unknown
Amyloidosis; Amyloidosis, Familial; Lymphoma, Large B-Cell, Diffuse; Multiple Myeloma; Neoplasms
Tubulin inhibitor
Antibody
Approved
Unknown
Unknown
Anemia, Hemolytic, Autoimmune; Colorectal Neoplasms; Hematologic Neoplasms; Immune System Diseases; Lymphoma, Large B-Cell, Diffuse; Amyloidosis, Familial; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Lymphoma; Paraproteinemias; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Red-Cell Aplasia, Pure; Smoldering Multiple Myeloma; Multiple Myeloma; Neoplasms
Lymphocyte differentiation antigen CD38 inhibitor
Antibody
Approved
Unknown
Unknown
Hemorrhagic Fever, Ebola
Envelope glycoprotein inhibitor
Antibody
Approved
Unknown
Unknown
Hematologic Neoplasms; Lymphoma; Multiple Sclerosis; Neoplasms; Scleroderma, Localized; Autoimmune Diseases of the Nervous System; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Multiple Myeloma; Immunoglobulin G4-Related Disease; Myasthenia Gravis; Scleroderma, Systemic; Neuromyelitis Optica
B-lymphocyte antigen CD19 binding agent
Antibody
Approved
Unknown
Unknown
Carcinoma, Squamous Cell; Lung Neoplasms; Carcinoma, Hepatocellular; Salivary Gland Neoplasms; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
Antibody
Approved
Unknown
Unknown
Esophageal Neoplasms; Liver Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Multiple Myeloma; Myelodysplastic Syndromes; Peritoneal Neoplasms; Adenocarcinoma, Follicular; Bile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colorectal Neoplasms; Dysgerminoma; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Glioblastoma; Head and Neck Neoplasms; HIV Infections; Lung Neoplasms; Mesothelioma; Neoplasms, Germ Cell and Embryonal; Neuroendocrine Tumors; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Seminoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Uveal Melanoma; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Melanoma; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Neoplasms
Cytotoxic T-lymphocyte protein 4 inhibitor
Antibody
Approved
Unknown
Unknown
Arthritis, Rheumatoid; Arthritis, Psoriatic; Hidradenitis Suppurativa; Spondylitis, Ankylosing; Immune System Diseases; Parapsoriasis; Psoriasis
Interleukin 17A inhibitor
Antibody
Approved
Unknown
Unknown
Wet Macular Degeneration
Vascular endothelial growth factor A binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Supranuclear Palsy, Progressive; Alzheimer Disease
Microtubule-associated protein tau inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Cell surface A33 antigen binding agent
Antibody
Investigational
Unknown
Unknown
Dermatitis, Atopic; Rhinitis, Allergic, Seasonal
Ig epsilon chain C region inhibitor
Antibody
Investigational
Unknown
Unknown
Influenza, Human
Tumor susceptibility gene 101 protein inhibitor
Antibody
Investigational
Unknown
Unknown
Melanoma
5,6-dihydroxyindole-2-carboxylic acid oxidase other
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
Unknown
Antibody
Unknown
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma
Transmembrane glycoprotein NMB binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Glycoprotein inhibitor
Antibody
Investigational
Unknown
Unknown
Graft vs Host Disease
Unknown
Antibody
Investigational
Unknown
Unknown
Carcinoma
Epithelial cell adhesion molecule binding agent
Antibody
Unknown
Unknown
Unknown
COVID-19
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Tubulin inhibitor
Antibody
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Tumor necrosis factor receptor superfamily member 8 binding agent
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms
Glutamate carboxypeptidase II binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Anemia
Hepcidin inhibitor
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Glutamate carboxypeptidase II binding agent
Antibody
Investigational
Unknown
Unknown
Autoimmune Diseases; Immunoglobulin G4-Related Disease; Pemphigus; Anemia, Hemolytic, Autoimmune; Myasthenia Gravis
IgG receptor FcRn large subunit p51 antagonist
Antibody
Unknown
Unknown
Unknown
Lymphoma, Large B-Cell, Diffuse
Unknown
Antibody
Investigational
Unknown
Unknown
Leukemia; Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell
Immunoglobulin epsilon Fc receptor antagonist
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Pancreatic Neoplasms
Frizzled-1 antagonist